Comments to Senate HELP Committee: Reasonable Pricing in the Pandemic and All-Hazards Preparedness Act July 7, 2023
Civil Society Organizations Comment to Center for Medicare: Therapeutic Alternative Prices as Starting Point in Drug Price Negotiations
Testimony: Preparing for the Next Public Health Emergency: Reauthorizing the Pandemic and All-Hazards Preparedness Act
Letter to Congress on World Diabetes Day: Expand Access to Insulin and Lower Prices November 14, 2022
Letter to Congressional Appropriators from Civil Society: Provide Urgent COVID-19 and MPXV Funding September 27, 2022